Literature DB >> 22200172

Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.

Mary Short1, Dominique Dallay, Salmon Omokanye, Jens Ulrich Hanisch, Pirjo Inki.   

Abstract

OBJECTIVES: To analyse the acceptability and patterns of use of the levonorgestrel releasing-intrauterine system (LNG-IUS) and the etonogestrel releasing-subdermal implant (ENG implant) among young European women.
METHODS: A total of 454 women aged 20-35 years opting to switch their method of contraception from oral contraception to the LNG-IUS or ENG implant, were recruited in an observational study in four different European countries (France, Ireland, Slovakia and the United Kingdom). The present paper reports the interim results of the study at 12 months of observation.
RESULTS: Data from 311 subjects (211 using the LNG-IUS and 100 using the ENG implant), with at least one follow-up visit after insertion, were analysed. The cumulative continuation rates at 12 months for the LNG-IUS and ENG implant were 93% and 86%, respectively. Most women were satisfied with their method of contraception after one year of follow-up (80% in the LNG-IUS group and 66% in the ENG implant group).
CONCLUSIONS: Both the LNG-IUS and the ENG implant are highly acceptable contraceptive options among women with previous experience of oral contraceptive use. The highest continuation and satisfaction rates were observed with the LNG-IUS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200172     DOI: 10.3109/13625187.2011.636088

Source DB:  PubMed          Journal:  Eur J Contracept Reprod Health Care        ISSN: 1362-5187            Impact factor:   1.848


  6 in total

1.  Continuation of reversible contraception in teenagers and young women.

Authors:  Jessica R Rosenstock; Jeffrey F Peipert; Tessa Madden; Qiuhong Zhao; Gina M Secura
Journal:  Obstet Gynecol       Date:  2012-12       Impact factor: 7.661

2.  Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.

Authors:  Tessa Madden; David L Eisenberg; Qiuhong Zhao; Christina Buckel; Gina M Secura; Jeffrey F Peipert
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

3.  Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.

Authors:  Nathaniel Henry; Charlie Hawes; Julia Lowin; Ingrid Lekander; Anna Filonenko; Helena K Kallner
Journal:  Acta Obstet Gynecol Scand       Date:  2015-06-17       Impact factor: 3.636

4.  A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.

Authors:  Kusum V Moray; Himanshu Chaurasia; Oshima Sachin; Beena Joshi
Journal:  Reprod Health       Date:  2021-01-06       Impact factor: 3.223

5.  Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review.

Authors:  Dustin Costescu; Rajinder Chawla; Rowena Hughes; Stephanie Teal; Martin Merz
Journal:  BMC Womens Health       Date:  2022-03-21       Impact factor: 2.809

Review 6.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.